Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated...
70 insider purchases on record · latest filing 2024-11-12.
Insiders have also filed 51 sale transactions at CLDX.